NYSE:MCKHealthcare
McKesson (MCK): Valuation Spotlight as Analyst Upgrades and Specialty Expansion Drive Fresh Investor Interest
McKesson (MCK) just expanded its specialty product lineup as Iterum Therapeutics announced that ORLYNVAH is now available for physicians through McKesson’s distribution channel. This comes alongside growing analyst optimism around the stock.
See our latest analysis for McKesson.
The upbeat momentum around McKesson has only grown this year, as a wave of analyst upgrades and new specialty distribution deals like ORLYNVAH have coincided with a rally in the stock. After surging nearly 31% over...